TLRY vs VEEV · rev $915.5M vs P/E 27, rev $1.81B
Tilray Inc (TLRY) versus Veeva Systems Inc Class A (VEEV) — a side-by-side from cached financials, not a winner call.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Veeva Systems Inc Class A (VEEV) is a health information services company listed on NYSE.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Latest reported VEEV revenue for 2026-07-31 was $1.81B. Net income was $534.4M. VEEV currently screens at market cap $25.15B and trailing P/E 27.5.
TLRY currently screens at market cap $573.9M. VEEV currently screens at market cap $25.15B and trailing P/E 27.5.
Not investment advice. Open the TLRY and VEEV stock pages for the full models.
Not investment advice.